C

Climb Bio Inc
D

CLYM

3.02000
USD
0.71
(30.74%)
مغلق
حجم التداول
154,449
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
144,188,194
المقالات

العنوان: Climb Bio Inc

القطاع: Healthcare
الصناعة: Biotechnology
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.